Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Vaccinex, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 1 | −11 |
| Shares | 335.5K | 46 | −335.5K (−100.0%) |
| Value | $1.14M | $45 | −$1.14M (−100.0%) |
New holders (0)
Institutions that held Vaccinex, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (11)
Institutions that held Vaccinex, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 166,000 | $564.4K |
| Armistice Capital, LLC | 164,000 | $557.6K |
| UBS Group AG | 3,402 | $11.6K |
| Tower Research Capital LLC (TRC) | 1,883 | $6.40K |
| Group One Trading, L.P. | 67 | $231 |
| Advisor Group Holdings, Inc. | 53 | $180 |
| Bank of America Corp | 24 | $82 |
| Morgan Stanley | 4 | $14 |
| Wells Fargo & Company | 2 | $7 |
| Royal Bank of Canada | 37 | $0 |
| Capital Advisors, Ltd. LLC | 3 | $0 |